LIXT (Lixte Biotechnology Holdings, Inc. Common Stock) Stock Analysis - Community

Lixte Biotechnology Holdings, Inc. Common Stock (LIXT) is a publicly traded Healthcare sector company. As of May 21, 2026, LIXT trades at $5.60 with a market cap of $54.60M and a P/E ratio of 0.00. LIXT moved +1.90% today. Year to date, LIXT is +48.15%; over the trailing twelve months it is +327.48%. Its 52-week range spans $0.64 to $6.26. Rallies surfaces LIXT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

How does the Rallies community trade LIXT?

Rallies community data for LIXT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.

LIXT Key Metrics

Key financial metrics for LIXT
MetricValue
Price$5.60
Market Cap$54.60M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$6.26
52-Week Low$0.64
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-6.01M
Gross Margin0.00%

Latest LIXT News

Recent LIXT Insider Trades

  • Bernards Rene bought 5.53K (~$13.87K) on Oct 3, 2023.
  • van der Baan Bastiaan Jeroen bought 10.00K (~$28.00K) on Oct 3, 2023.
  • Bernards Rene bought 5.53K (~$13.87K) on Oct 3, 2023.

LIXT Analyst Consensus

LIXT analyst coverage data. Average price target: $0.00.

Common questions about LIXT

How does the Rallies community trade LIXT?
Rallies community data for LIXT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for LIXT?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for LIXT when enough community data is available.
Is LIXT research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LIXT. It does not provide personalized investment advice.
LIXT

LIXT